Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-08

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Modavar Pharmaceuticals LLC)

View source ↗

Summary

FDA approved olmesartan medoxomil as a generic product from Modavar Pharmaceuticals LLC under an Original Application (ANDA) for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)